Daily NSE closing prices — this stock isn't in the live-tracked universe yet.
NSE Close — 25 Sep 2026
₹232.85
Change
+10.41 (4.68%)
Open
₹222.25
Prev. Close
₹222.44
Day High
₹234.0
Day Low
₹220.05
Volume Analysis
Traded
120,424
Delivered
54,197
Delivery %
45.01%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Trading within 3% of its 52-week high (₹239.0)
Weaknesses (1)
- •Below-average fundamentals quality score (45/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹251.84 | ₹242.92 | ₹237.89 | ₹228.97 | ₹223.94 | ₹215.02 | ₹209.99 |
| Fibonacci | ₹242.92 | ₹237.59 | ₹234.3 | ₹228.97 | ₹223.64 | ₹220.35 | ₹215.02 |
| Camarilla | ₹236.69 | ₹235.41 | ₹234.13 | ₹228.97 | ₹231.57 | ₹230.29 | ₹229.01 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
+4.0%
1 Month
—
3 Months
—
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
16.12%
Net margin 6.07% × asset turnover 1.61x × equity multiplier 1.65x
Company Overview
Sector
Healthcare
Market Cap
₹466 Cr
P/E (TTM)
93.9
ROE
16.1%
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Rays Of Belief Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 45/100. The strongest factor is Financial Strength (100/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week high (₹239.0); below-average fundamentals quality score (45/100).
TopFund Score — Fundamentals Quality
45/100 — WeakData confidence: 67/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Rays of Belief acquired 100% of City Pro Group via subsidiary, effective September 18, 2026.
100% acquisition of City Pro Group Inc. for USD 2 million; became step-down subsidiary on September 18, 2026.
Board approved USD 2 million investment in Mom’s Belief US Inc on 17 September 2026.
Source: BSE regulatory filings, via Screener.in.
Profit & Loss (Yearly)
| Mar 2026 | |
|---|---|
| Sales + | 82 |
| Expenses + | 69 |
| Operating Profit | 12 |
| OPM % | 15.14% |
| Other Income + | 0 |
| Interest | 2 |
| Depreciation | 4 |
| Profit before tax | 7 |
| Tax % | 28.08% |
| Net Profit + | 5 |
| EPS in Rs | 3 |
| Dividend Payout % | 0.0% |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2026 | |
|---|---|
| Reserves | 15 |
| Borrowings + | 9 |
| Other Liabilities + | 11 |
| Total Liabilities | 51 |
| Fixed Assets + | 12 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets + | 39 |
| Total Assets | 51 |
| Equity Capital | 16 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2026 | |
|---|---|
| Cash from Operating Activity + | -2 |
| Cash from Investing Activity + | -6 |
| Cash from Financing Activity + | 6 |
| Net Cash Flow | -2 |
| CFO/OP | -15 |
| Free Cash Flow | -3 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2026 | |
|---|---|
| Public | 11.65% |
| Promoters | 68.77% |
| FII | 8.34% |
| DII | 11.24% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Rays Of Belief Limited (this stock) | 466 | 93.9 | — | 16.1% |
| Haleos Labs Limited | 444 | 28.1 | 2.08 | 8.44% |
| Medicamen Biotech Limited | 428 | 39.4 | 1.55 | 3.95% |
| Qms Medical Allied S Ltd | 380 | 35.4 | 3.65 | 10.4% |
| Nureca Limited | 335 | 77.3 | 1.86 | 1.12% |
| Ambalal Sarabhai Ent L | 316 | 22.2 | 2.0 | 12.4% |
| Lyka Labs Ltd. | 310 | — | 3.31 | -10.2% |
Which Mutual Funds Hold Rays Of Belief Limited?
Frequently Asked Questions about Rays Of Belief Limited
Rays Of Belief Limited (MOMSBELIEF) closed at ₹232.85 on NSE on 25 September 2026, up 10.41 (4.68%) from the previous close.
Rays Of Belief Limited trades on the NSE (National Stock Exchange of India) under the symbol MOMSBELIEF.
Rays Of Belief Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 93.9.
Rays Of Belief Limited has a dividend yield of 0.0%.
Rays Of Belief Limited's 52-week high is ₹239.0 and its 52-week low is ₹208.0.
Rays Of Belief Limited has a market capitalisation of ₹466 crore.
Rays Of Belief Limited has a TopFund Quality Score of 45/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Rays Of Belief Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.